Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynsey M Whilding

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunotherapy|March 26, 2015
ErbB-targeted CAR T-cell immunotherapy of cancerLynsey M Whilding, John Maher
Molecular Oncology|November 14, 2015
CAR T-cell immunotherapy: The path from the by-road to the freeway?Lynsey M Whilding, John Maher
Biochemical Society Transactions|April 13, 2016
The integrin αvβ6: a novel target for CAR T-cell immunotherapy?Lynsey M Whilding, Sabari Vallath, John Maher
Frontiers in Immunology|June 11, 2019
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Frontiers in Immunology|December 28, 2020
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Vaccinia virus induces programmed necrosis in ovarian cancer cellsLynsey M Whilding, Kyra M Archibald, Hagen Kulbe, et al.
Cancers|May 17, 2019
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid MalignanciesLynsey M Whilding, Leena Halim, Benjamin Draper, et al.
Biology|March 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer ImmunotherapyDavid M Davies, Giuseppe Pugliese, Ana C Parente Pereira, et al.
STAR Protocols|May 2, 2022
Generation and application of TGFβ-educated human Vγ9Vδ2 T cellsAna C Parente-Pereira, Richard E Beatson, David M Davies, et al.
Advanced Healthcare Materials|April 14, 2015
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killingPei Yun Teo, Chuan Yang, Lynsey M Whilding, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunotherapy|March 26, 2015
ErbB-targeted CAR T-cell immunotherapy of cancerLynsey M Whilding, John Maher
Molecular Oncology|November 14, 2015
CAR T-cell immunotherapy: The path from the by-road to the freeway?Lynsey M Whilding, John Maher
Biochemical Society Transactions|April 13, 2016
The integrin αvβ6: a novel target for CAR T-cell immunotherapy?Lynsey M Whilding, Sabari Vallath, John Maher
Frontiers in Immunology|June 11, 2019
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Frontiers in Immunology|December 28, 2020
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Vaccinia virus induces programmed necrosis in ovarian cancer cellsLynsey M Whilding, Kyra M Archibald, Hagen Kulbe, et al.
Cancers|May 17, 2019
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid MalignanciesLynsey M Whilding, Leena Halim, Benjamin Draper, et al.
Biology|March 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer ImmunotherapyDavid M Davies, Giuseppe Pugliese, Ana C Parente Pereira, et al.
STAR Protocols|May 2, 2022
Generation and application of TGFβ-educated human Vγ9Vδ2 T cellsAna C Parente-Pereira, Richard E Beatson, David M Davies, et al.
Advanced Healthcare Materials|April 14, 2015
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killingPei Yun Teo, Chuan Yang, Lynsey M Whilding, et al.
Pageof 3